Electromedical Technologies Files Amended 2023 10-K
Ticker: EMED · Form: 10-K/A · Filed: Oct 16, 2024 · CIK: 1715819
Sentiment: neutral
Topics: amendment, annual-report, medical-devices
TL;DR
EMED filed its amended 2023 10-K. Check for updates.
AI Summary
Electromedical Technologies, Inc. filed an amended 10-K report for the fiscal year ended December 31, 2023. The company, incorporated in Delaware, is involved in the Surgical & Medical Instruments & Apparatus industry. Their principal executive offices are located in Scottsdale, Arizona.
Why It Matters
This amended filing provides updated financial and operational information for Electromedical Technologies, Inc., which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and does not introduce new material risks.
Key Numbers
- 2023-12-31 — Fiscal Year End (The report covers the period ending on this date.)
Key Players & Entities
- Electromedical Technologies, Inc. (company) — Registrant
- 2023-12-31 (date) — Fiscal Year End
- Scottsdale, AZ (location) — Business Address
- 888-880-7888 (phone_number) — Business Phone
FAQ
What is the primary purpose of this 10-K/A filing?
This is an amended annual report (10-K/A) for the fiscal year ended December 31, 2023, filed by Electromedical Technologies, Inc.
When was this amended filing submitted?
The filing was submitted on October 16, 2024, with a change date of October 15, 2024.
What industry does Electromedical Technologies, Inc. operate in?
The company operates in the 'Surgical & Medical Instruments & Apparatus' industry, with SIC code 3841.
Where is Electromedical Technologies, Inc. headquartered?
The company's principal executive offices are located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260.
What is the SEC file number for Electromedical Technologies, Inc.?
The SEC file number for the registrant is 000-56192.
Filing Stats: 961 words · 4 min read · ~3 pages · Grade level 11.4 · Accepted 2024-10-15 18:51:52
Key Financial Figures
- $0 — 2,757 shares of common stock, par value $0.00001, were issued and outstanding. 1
Filing Documents
- emed20231231_10ka.htm (10-K/A) — 36KB
- ex_730393.htm (EX-31.1A) — 7KB
- ex_730394.htm (EX-31.2A) — 7KB
- electrologo.jpg (GRAPHIC) — 15KB
- 0001437749-24-031282.txt ( ) — 299KB
- emed-20231231.xsd (EX-101.SCH) — 3KB
- emed-20231231_def.xml (EX-101.DEF) — 17KB
- emed-20231231_lab.xml (EX-101.LAB) — 24KB
- emed-20231231_pre.xml (EX-101.PRE) — 18KB
- emed20231231_10ka_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 15, 2024 By: /s/Matthew Wolfson Matthew Wolfson Chief Executive Officer, Chief Financial Officer 2